Clinical practitioners frequently struggle with block-wise modality missingness, where budget constraints or technical failures prevent the collection of comprehensive molecular profiles for every patient. This foundational challenge arises in an era where the medical community seeks to transition
The lifelong requirement for invasive cystoscopy surveillance places an immense physical and financial burden on patients diagnosed with recurrent bladder cancer. This burden has sparked a significant paradigm shift in how urothelial carcinoma is managed, steering the medical community away from
By leveraging a system of base and fibre posets, computational chemists can now characterize the search space for new drugs with mathematical precision and formal semantics. The pharmaceutical industry is currently witnessing a significant shift as artificial intelligence moves from being an
Developing a portable tool for longitudinal disease modeling under heterogeneous supervision provides a template that can be applied to oncology, cardiology, and respiratory medicine. This specific breakthrough addresses the persistent challenge of Chronic Kidney Disease (CKD), a condition that
Reliability and standardization are the new metrics of success as the industry attempts to ensure that biological data is reproducible across different batches and global locations. This shift follows a decade of intense focus on the computational "dry lab" side of drug discovery, where artificial
Autonomous laboratories are reducing the cost of innovation by allowing researchers to explore broad scientific domains with a minimal number of physical experiments. This shift represents a fundamental transformation in how LG AI Research approaches machine intelligence, moving away from broad,
